KYAH MILES: Open Payments
NPI 1043512445 · SAINT PAUL, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 13 payments from 11 companies in 2025. Trend: 2023 $107 · 2024 $72 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $17 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| CSL Behring | 1 | $16 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| GENZYME CORPORATION | 1 | $14 |
| Verona Pharma, Inc. | 1 | $14 |
Products named: TEZSPIRE, DUPIXENT, Xolair, Sajazir, Haegarda, RUCONEST, XHANCE, FASENRA.
Industry payments across MN — which companies pay providers there.
